Diverse leukemia stem cells may drive AML relapse after therapy
Scientists from the German Cancer Research Center (DKFZ) and the HI-STEM* Stem Cell Institute have deciphered a key mechanism that contributes to treatment failure in acute myeloid leukemia (AML).
8 May 03:22 · News-Medical